Citation: R. Kalviainen et I. Nousiainen, Visual field defects with vigabatrin - Epidemiology and therapeutic implications, CNS DRUGS, 15(3), 2001, pp. 217-230
Authors:
Salmenpera, T
Kalviainen, R
Partanen, K
Pitkanen, A
Citation: T. Salmenpera et al., Hippocampal and amygdaloid damage in partial epilepsy - A cross-sectional MRI study of 241 patients, EPILEPSY R, 46(1), 2001, pp. 69-82
Authors:
Lamusuo, S
Jutila, L
Ylinen, A
Kalviainen, R
Mervaala, E
Haaparanta, M
Jaaskelainen, S
Partanen, K
Vapalahti, M
Rinne, J
Citation: S. Lamusuo et al., [F-18]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage, ARCH NEUROL, 58(6), 2001, pp. 933-939
Authors:
Schmidt, D
Arroyo, S
Baulac, M
Dam, M
Dulac, O
Friis, ML
Kalviainen, R
Kramer, G
van Parys, J
Pedersen, B
Sachdeo, R
Citation: D. Schmidt et al., Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view, ACT NEUR SC, 104(3), 2001, pp. 167-170
Authors:
Nousiainen, I
Mantyjarvi, M
Kalviainen, R
Citation: I. Nousiainen et al., Visual function in patients treated with the GABAergic anticonvulsant drugtiagabine, CLIN DRUG I, 20(6), 2000, pp. 393-400
Authors:
Schmidt, D
Gram, L
Brodie, M
Kramer, G
Perucca, E
Kalviainen, R
Elger, CE
Citation: D. Schmidt et al., Tiagabine in the treatment of epilepsy - a clinical review with a guide for the prescribing physician, EPILEPSY R, 41(3), 2000, pp. 245-251
Authors:
Salmenpera, T
Kalviainen, R
Partanen, K
Mervaala, E
Pitkanen, A
Citation: T. Salmenpera et al., MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus, EPILEPSY R, 40(2-3), 2000, pp. 155-170
Authors:
Nousiainen, I
Kalviainen, R
Mantyjarvi, M
Citation: I. Nousiainen et al., Color vision in epilepsy patients treated with vigabatrin or carbamazepinemonotherapy, OPHTHALMOL, 107(5), 2000, pp. 884-888
Authors:
Lamusuo, S
Pitkanen, A
Jutila, L
Ylinen, A
Partanen, K
Kalviainen, R
Ruottinen, HM
Oikonen, V
Nagren, K
Lehikoinen, P
Vapalahti, M
Vainio, P
Rinne, JO
Citation: S. Lamusuo et al., [C-11]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy - Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology, NEUROLOGY, 54(12), 2000, pp. 2252-2260
Authors:
Nousiainen, I
Kalviainen, R
Mantyjarvi, M
Citation: I. Nousiainen et al., Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers, BR J OPHTH, 84(6), 2000, pp. 622-625
Authors:
Aikia, M
Kalviainen, R
Mervaala, E
Riekkinen, PJ
Citation: M. Aikia et al., Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor, EPILEPSY R, 37(2), 1999, pp. 159-167
Citation: R. Kalviainen, Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy, J INTEL DIS, 42, 1998, pp. 63-67
Authors:
Mikkonen, M
Soininen, H
Kalviainen, R
Tapiola, T
Ylinen, A
Vapalahti, M
Paljarvi, L
Pitkanen, A
Citation: M. Mikkonen et al., Remodeling of neuronal circuitries in human temporal lobe epilepsy: Increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex, ANN NEUROL, 44(6), 1998, pp. 923-934